ScinoPharm Taiwan Market Cap

ScinoPharm Taiwan has a market cap or net worth of 17.79 billion as of January 31, 2025. Its market cap has decreased by -13.79% in one year.

Market Cap

17.79B

Enterprise Value

14.49B

Revenue

3.49B

Ranking

n/a

PE Ratio

44.55

Stock Price

22.50

Market Cap Chart

Since October 29, 2010, ScinoPharm Taiwan's market cap has decreased from 30.44B to 17.79B, a decrease of -41.54%. That is a compound annual growth rate of -3.70%.

Market Cap History

Date	Market Cap	% Change
Jan 22, 2025	17.79B	2.04%
Dec 31, 2024	17.44B	-16.48%
Dec 29, 2023	20.88B	3.73%
Dec 30, 2022	20.12B	3.25%
Dec 30, 2021	19.49B	-14.56%
Dec 31, 2020	22.81B	8.46%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	228.69B
Caliway Biopharmaceuticals	107.10B
Bora Pharmaceuticals Co., LTD.	83.09B
Lotus Pharmaceutical	68.47B
Lumosa Therapeutics	40.03B
Oneness Biotech	37.72B
Polaris Group	33.47B
Center Laboratories	29.00B

Market Cap Rankings